Calcific uremic arteriolopathy (Calcyphilaxis): a... (2015 study) Skip to main content
Case Report G Ital Nefrol 2015

Calcific uremic arteriolopathy (Calcyphilaxis): a rare disease? Report of three cases

Napolitano P, Capuano A, D'Apice L, Mosella F, Pota A, Saviano C, et al., G Ital Nefrol, 2015

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers described three patients on dialysis who developed calcific uremic arteriolopathy (calciphylaxis), a condition with skin lesions, and reported how a combined set of treatments went.

What They Found

This case report of three dialysis patients with calcific uremic arteriolopathy found that a multi-part treatment plan was followed by lower blood PTH, calcium and phosphorus levels, and complete healing of skin ulcers in two of the three patients. The mean age at diagnosis was 56 years (range 33-68). Mean PTH fell from 1277 pg/ml to 331 pg/ml, mean serum calcium from 10.2 to 8.3 mg/dl, and mean phosphorus from 4.5 to 3.4 mg/dl. The treatment plan stopped calcium-based phosphate binders, vitamin D and warfarin, started cinacalcet and sodium thiosulfate, used low-calcium dialysate (1.25 mmol/l), used Hyperbaric Oxygen Therapy, and included surgical dressings of skin lesions three times a week.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a report of only three patients with no comparison group, so it cannot show that any single treatment, including hyperbaric oxygen, caused the improvements, and one of the three patients did not achieve complete healing.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Uncategorised
Source Pubmed
PubMed ID 25774581
Year Published 2015
Journal G Ital Nefrol
MeSH Terms Adult; Aged; Calciphylaxis; Chelating Agents; Female; Humans; Kidney Failure, Chronic; Male; Rare Diseases; Renal Dialysis; Skin Diseases, Vascular; Syndrome; Vitamin D; Vitamins; Withholding Treatment

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology